xml: <clinical_study>
    <!-- This xml conforms to an XML Schema at:
      https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
    <required_header>
      <download_date>ClinicalTrials.gov processed this data on September 20, 2023</download_date>
      <link_text>Link to the current ClinicalTrials.gov record.</link_text>
      <url>https://clinicaltrials.gov/ct2/show/NCT05982067</url>
    </required_header>
    <id_info>
      <org_study_id>Mindful PE Sarcope</org_study_id>
      <nct_id>NCT05982067</nct_id>
    </id_info>
    <brief_title>MIndfulness-based Physical Exercise Program (MIPE Program) on Sarcopenia</brief_title>
    <official_title>The Utility of MIndfulness-based Physical Exercise Program (MIPE Program) for Community-dwelling Older People With Sarcopenia: a Pilot Randomised Controlled Trial</official_title>
    <sponsors>
      <lead_sponsor>
        <agency>The Hong Kong Polytechnic University</agency>
        <agency_class>Other</agency_class>
      </lead_sponsor>
    </sponsors>
    <source>The Hong Kong Polytechnic University</source>
    <oversight_info>
      <is_fda_regulated_drug>No</is_fda_regulated_drug>
      <is_fda_regulated_device>No</is_fda_regulated_device>
    </oversight_info>
    <brief_summary>
      <textblock>
        The goal of this pilot randomized controlled trial (RCT) is to assess the feasibility,&#xD;
        acceptability, and the preliminary effects of the MIndfulness-based Physical Exercise (MIPE)&#xD;
        intervention among community-dwelling older people with sarcopenia. The main questions are:&#xD;
        1) is the MIPE intervention feasible and acceptable in older adults with sarcopenia? 2) is&#xD;
        the MIPE intervention effective to improve the adherence to physical exercise intervention,&#xD;
        alleviate the symptoms of sarcopenia and enhance the psychological well-being of older adults&#xD;
        with sarcopenia? To answer these questions, a MIPE intervention protocol was developed by&#xD;
        Delphi approach and end-users' evaluation. This pilot RCT will be conducted to assess the&#xD;
        feasibility, acceptability, and the preliminary effects of the MIPE intervention. In the&#xD;
        parallel-group, pilot RCT, 60 community-dwelling older people aged 60 years or older&#xD;
        diagnosed with sarcopenia will be randomized into either the intervention group receiving the&#xD;
        MIPE intervention 2 sessions weekly over 12 weeks or the control group receiving health&#xD;
        educations. Each session of the MIPE intervention will last about 70 minutes, including&#xD;
        20-min mindfulness-based intervention, 40-min physical exercise (10-min warm-up, 20-min RE,&#xD;
        and 10-min cool down) and 10-20-min sharing and discussion. The feasibility, acceptability&#xD;
        and preliminary effectiveness on sarcopenia symptoms and psychological well-being of the MIPE&#xD;
        program will be assessed.&#xD;
      </textblock>
    </brief_summary>
    <detailed_description>
      <textblock>
        Background Sarcopenia is a geriatric syndrome characterised by low muscle mass, muscle&#xD;
        strength, and physical function. Physical exercise (PE), especially resistance exercise, has&#xD;
        demonstrated potential effects on sarcopenia. However, low motivation for regular PE is&#xD;
        always reported as a major barrier in this population. Based on the PRIME (Plans, Responses,&#xD;
        Impulses, Motives, and Evaluations) theory of motivation, Plan (i.e., well-planned, and&#xD;
        evidence-based PE protocol), Motives (anticipated pleasure, satisfaction, and relief) and&#xD;
        self-awareness on the present moment are the key points of human motivation and the potential&#xD;
        targets to change a behaviour (i.e., adhering to a PE intervention) in older people with&#xD;
        sarcopenia. Limited study on sarcopenia consisted of any interventional element to emphasise&#xD;
        motives and self-awareness on the present moment, two key points of human motivation in the&#xD;
        PRIME theory of motivation, although older people with sarcopenia are more likely to have&#xD;
        negative feelings (i.e., fatigue, depress, anxiety) and experiences (i.e., derailed by daily&#xD;
        life and distracted by concerns on PE). Mindfulness-based intervention (MBI) is a&#xD;
        psychosocial intervention which aims to increase the participants' awareness of the present&#xD;
        moment non-judgmentally. Increased evidence has indicated that MBI can also improve the&#xD;
        levels of PE and adherence to PE interventions. Based on the mindful coping model, the&#xD;
        positive relationship between mindfulness and PE might be that MBI has the potential to&#xD;
        improve motivation for PE by addressing three key points of human motivation in the PRIME&#xD;
        theory of motivation (focusing on the present moment, evoking positive feelings, and&#xD;
        increasing self-awareness). Thus, MBI has the potential to be integrated into PE training to&#xD;
        increase motivation and adherence to PE in older people with sarcopenia.&#xD;
  &#xD;
        To address the above research gaps, we first conducted a SR on the home-based interventions&#xD;
        among community-dwelling older people with sarcopenia was conducted, showing that home-based&#xD;
        resistance exercise is feasible, suitable and has potential effects on sarcopenia, but few&#xD;
        studies consisted of motivation-enhancing component. Then a Delphi study was conducted to&#xD;
        develop the MIndfulness-based Physical Exercise (MIPE) intervention on this population.&#xD;
        However, the feasibility, acceptability, and effects of the HOME intervention among&#xD;
        community-dwelling older people with sarcopenia need to be explored.&#xD;
  &#xD;
        Objective The objective of this study is to assess the feasibility, acceptability, and the&#xD;
        preliminary effects of the MIPE intervention among community-dwelling older people with&#xD;
        sarcopenia.&#xD;
  &#xD;
        Methods A pilot randomised controlled trial (RCT) will be conducted to assess the&#xD;
        feasibility, acceptability, and the preliminary effects of the HOME intervention. In the&#xD;
        parallel-group, pilot RCT, 60 community-dwelling older people aged 60 years or older&#xD;
        diagnosed with sarcopenia will be randomised into either the intervention group receiving the&#xD;
        HOME intervention 2 sessions weekly over 12 weeks or the control group receiving health&#xD;
        educations. Each session of the HOME intervention will last about 70 minutes, including&#xD;
        20-min MBI, 40-min HBE (10-min warm-up, 20-min RE, and 10-min cool down) and 10-20-min&#xD;
        sharing and discussion. The feasibility of this programme will be determined by time spent&#xD;
        recruiting participants, eligibility rate and recruitment rate. The acceptability of the HOME&#xD;
        program will be assessed by: 1) prospective acceptability: recruitment rate and reasons for&#xD;
        not involving in this study; 2) concurrent acceptability: attendance rate, complete rate,&#xD;
        attrition rate and reasons for discontinuing; and 3) retrospective acceptability: the&#xD;
        participants' perspectives on the intervention after taking part. Based on our conceptual&#xD;
        framework, primary outcomes (muscle mass, muscle strength and physical function) and&#xD;
        secondary outcomes (motivation, depressive symptoms, psychological well-being, mindfulness&#xD;
        level and quality of life) will be assessed at baseline (T0), immediately post-intervention&#xD;
        week 12 (T1) and 12 weeks after completion of the intervention. The quantitative data will be&#xD;
        analysed by generalised estimating equations. The qualitative data will be Brun and Clark's&#xD;
        thematic approach.&#xD;
  &#xD;
        Impact and significance The MIPE program, consisting MBI and PE, is novel in the research&#xD;
        field related to sarcopenia, which addresses the limitations of previous studies. This study&#xD;
        has the potential to improve the symptoms of sarcopenia, the motivation and adherence to PE&#xD;
        as well as the psychological health of this population, which finally improves the holistic&#xD;
        welling of this population and facilitates their &quot;ageing in place&quot;. For researchers, this&#xD;
        study provides a relatively new sub-area in this field by generating insights on the&#xD;
        importance of the above factors and the potential effectiveness of the mindfulness-based PE.&#xD;
        For health professionals, the study provides a potentially effective way to improve the&#xD;
        motivation and adherence to PE to treat sarcopenia.&#xD;
      </textblock>
    </detailed_description>
    <overall_status>Recruiting</overall_status>
    <start_date type="Actual">July 25, 2023</start_date>
    <completion_date type="Anticipated">December 30, 2023</completion_date>
    <primary_completion_date type="Anticipated">December 30, 2023</primary_completion_date>
    <phase>N/A</phase>
    <study_type>Interventional</study_type>
    <has_expanded_access>No</has_expanded_access>
    <study_design_info>
      <allocation>Randomized</allocation>
      <intervention_model>Parallel Assignment</intervention_model>
      <primary_purpose>Treatment</primary_purpose>
      <masking>Double (Investigator, Outcomes Assessor)</masking>
      <masking_description>Due to the character of the intervention and control group in this study (the mindfulness-based PE vs health education), it is impossible to blind participants. The interventionist (the qualified mindfulness instructor and sport coach) is also unrealizable to be blinded. To reduce the allocation bias as much as possible, the following personnel will be blinded: the research assistants who are responsible for the participants recruitment, the research assistants who perform the randomization and the assessor who collect data.</masking_description>
    </study_design_info>
    <primary_outcome>
      <measure>Time spent recruiting participants</measure>
      <time_frame>baseline (T0)</time_frame>
      <description>The time spent recruiting participants is the period from the first day of recruiting participants to the last day of recruiting participants. This outcome will help us understand the feasibility of the MIPE program. Specifically, shorter time spent recruiting participants roughly reflects the higher feasibility of the MIPE program.</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Eligibility rate</measure>
      <time_frame>baseline (T0)</time_frame>
      <description>The eligibility rate will be calculated by the number of eligible participants/the number of screened participants. The higher eligibility indicates the more potential participants.</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Recruitment rate</measure>
      <time_frame>baseline (T0)</time_frame>
      <description>The recruitment rate will be calculated by the number of participants recruited/ the number of eligible participants. The higher recruitment rate indicates the higher willingness of the eligible participants to join the MIPE program.</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Attendance rate</measure>
      <time_frame>week 12 (T1)</time_frame>
      <description>The attendance rate will be calculated by the attended sessions of the participants/ all sessions. The higher attendance rate roughly indicates the higher involvement of the participants in the MIPE program.</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Complete rate</measure>
      <time_frame>week 12 (T1)</time_frame>
      <description>The complete rate will be calculated by the sessions that finished at least 80% / all attended sessions. The higher complete rate indicates the actual involvement of the participants in the MIPE program.</description>
    </primary_outcome>
    <primary_outcome>
      <measure>Attrition rate</measure>
      <time_frame>week 12 (T1)</time_frame>
      <description>The attrition rate will be calculated by the number of participants dropped out total number of participants. If the participants engage in less than 80% of online sessions will be considered as attrition. The higher attrition rate indicates the lower participation in the MIPE program.</description>
    </primary_outcome>
    <primary_outcome>
      <measure>The participants' perspectives on the intervention</measure>
      <time_frame>week 12 (T1)</time_frame>
      <description>The participants' perspectives on the intervention will be explored by individual interviews. There are mainly five questions in the individual interviews: 1) Generally, what do you think of this intervention? 2) What do you think of the content of this intervention? 3) What do you think of the frequency, duration and delivery mode of this intervention? 4) How about your motivation to exercise? 5) What recommendations do you have for this intervention? The results will help us to further revise and improve the MIPE to be more tailored to the older adults with sarcopenia. The individual interviews will be conducted by the PhD student who has received rigor trained in qualitative study methods and engaged in individual interviews before and a professor who has rich experience in conducting individual interviews and is familiar with sarcopenia and mindfulness.</description>
    </primary_outcome>
    <secondary_outcome>
      <measure>Skeletal muscle mass index</measure>
      <time_frame>baseline (T0) and week 12 (T1, immediately post-intervention)</time_frame>
      <description>Skeletal muscle mass index (SMI) will be assessed by Bioelectrical impedance analysis (Inbody 270, Korea). The procedure of testing is below: before the test, the participants will be required to remove every item that might influence the test, such as metal keys, bank cards, mobile phones, from their body, and then take off their shoes and socks. Then, they will be instructed to stand straight on the detector with two hands holding the handles of the detector for about one minute. During the testing, they will be not allowed to talk, move, or laugh. Higher Skeletal muscle mass index (SMI) means the higher muscle mass. Comparisons of changes of skeletal muscle mass index (SMI) will be considered as follows: baseline (T0)- week 12 (T1).</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>The Chinese version of the Behavioral Regulation in Exercise Questionnaire-2 (C-BREQ-2)</measure>
      <time_frame>baseline (T0) and week 12 (T1, immediately post-intervention)</time_frame>
      <description>The Chinese version of the Behavioral Regulation in Exercise Questionnaire-2 (C-BREQ-2) assesses the motivation of the participants to exercise. The C-BREQ-2 is a self-report measure with 18-items and each item is rated on a 5-point Likert scale from 0 to 4, with a higher score indicating higher motivation to exercise. Comparison of change of the C-BREQ-2 will be considered as follows: baseline (T0)- week 12 (T1).</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>The Chinese version of the short form Geriatric Depression Scale (GDS-15)</measure>
      <time_frame>baseline (T0) and week 12 (T1, immediately post-intervention)</time_frame>
      <description>The Chinese version of the short form Geriatric Depression Scale (GDS-15) assesses the depressive symptoms of the participants. The score of GDS ranges 0-15 with each &quot;no&quot; answers of item 1,5,7 and 11 scoring 1 while the rest items scoring 1 with &quot;yes&quot; answers. The classification of depressive symptoms based on the score is: score 0-4: normal; score 5-8: mild depression; score 9-11: moderate depression; score 12-15: severe depression. Comparison of change of the Chinese version of the GDS-15 will be considered as follows: baseline (T0)- week 12 (T1).</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>The Chinese version of Raff's Psychological Well-being Scale (RPWS-C)</measure>
      <time_frame>baseline (T0) and week 12 (T1, immediately post-intervention)</time_frame>
      <description>The Chinese version of Raff's Psychological Well-being Scale (RPWS-C) assesses the psychological well-being of the participants. The RPWS-C has 24 items, and each item is rated from 1 (strongly disagree) to 6 (strongly agree), with higher score indicating higher psychological well-being. Comparison of change of the RPWS-C will be considered as follows: baseline (T0)- week 12 (T1).</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>The Chinese Version of the Physical Activity Scale for the Elderly (PASE-C)</measure>
      <time_frame>baseline (T0) and week 12 (T1, immediately post-intervention)</time_frame>
      <description>The Chinese Version of the Physical Activity Scale for the Elderly (PASE-C) assesses the physical activity level of the participants. The PASE-C, consisting of 10-items, is a self-reported scale to measure the occupational, household, and leisure activities for the last seven days. Higher score of the PASE-C indicates higher physical activity. Comparison of change of the PASE-C will be considered as follows: baseline (T0)- week 12 (T1).</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>The Chinese version of Five Facet Mindfulness Questionnaire (FFMQ-15-C)</measure>
      <time_frame>baseline (T0) and week 12 (T1, immediately post-intervention)</time_frame>
      <description>The Chinese version of Five Facet Mindfulness Questionnaire (FFMQ-15-C) assesses the mindfulness level of the participants. The FFMQ-15-C has 15 items and each item is rated on a 5-point Likert scale, ranging from1 = &quot;never or very rarely true&quot; to 5 = &quot;very often or always true&quot;, with higher total scores indicating a higher degree of mindfulness. Comparison of change of the FFMQ-15-C will be considered as follows: baseline (T0)- week 12 (T1).</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>The Chinese version of Sarcopenia and Quality of life (SarQoL®)</measure>
      <time_frame>baseline (T0) and week 12 (T1, immediately post-intervention)</time_frame>
      <description>The Chinese version of Sarcopenia and Quality of life (SarQoL®) assesses the quality of life of the participants. The SarQoL® has 22 items with higher score indicating higher quality of life. Comparison of change of the SarQoL® will be considered as follows: baseline (T0)- week 12 (T1).</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>Handgrip strength</measure>
      <time_frame>baseline (T0) and week 12 (T1, immediately post-intervention)</time_frame>
      <description>Handgrip strength will be measured by Jamar dynamometer (Jamar, 563213, USA) and the method refers to the recommendation of American Society of Hand Therapists. Comparisons of changes of handgrip strength will be considered as follows: baseline (T0)- week 12 (T1).</description>
    </secondary_outcome>
    <secondary_outcome>
      <measure>5-times Chair stand test</measure>
      <time_frame>baseline (T0) and week 12 (T1, immediately post-intervention)</time_frame>
      <description>5-times Chair stand test reflects the physical function and is an indicator in the sarcopenia diagnosis. The participants will be invited to stand and sit from a chair (about 43 cm) five times and the time will be recorded. Short time of the test, better physical function. Comparisons of changes of 5-times Chair stand test will be considered as follows: baseline (T0)- week 12 (T1).</description>
    </secondary_outcome>
    <number_of_arms>2</number_of_arms>
    <enrollment type="Anticipated">60</enrollment>
    <condition>Sarcopenia</condition>
    <arm_group>
      <arm_group_label>mindfulness-based physical exercie</arm_group_label>
      <arm_group_type>Experimental</arm_group_type>
      <description>The participants will receive about 70-min MIPE program twice a week, which will be conducted in a hybrid way, a combination of face-to-face and at home by a qualified mindfulness therapist and a sport coach.</description>
    </arm_group>
    <arm_group>
      <arm_group_label>Health education</arm_group_label>
      <arm_group_type>Placebo Comparator</arm_group_type>
      <description>Health education consisting of discussion provided by a registered nurse will be conducted as a control of socialization and interaction.</description>
    </arm_group>
    <intervention>
      <intervention_type>Other</intervention_type>
      <intervention_name>mindfulness-based phsycial exercise intervention</intervention_name>
      <description>The intervention is 12 weeks, two times a week. The MIPE intervention will be conducted in a hybrid way, a combination of face-to-face and at home, by a qualified mindfulness therapist and a qualified sport coach. Specifically, the participants will attend the face-to-face sessions once every two weeks and in other weeks, they will perform the intervention at home using videos and templates. The face-to-face sessions will be conducted at the health care centre. The intervention of each session will include 1) introduce the theme of this session, 2) mini lectures about the theme; 3) mindfulness practice related to the theme; 4) tips of keeping mindfulness during PE; 5) warm up: lead with mindfulness words; 6) resistance exercise; 7) cool down: lead with mindfulness words; 8) discussion.</description>
      <arm_group_label>mindfulness-based physical exercie</arm_group_label>
    </intervention>
    <intervention>
      <intervention_type>Other</intervention_type>
      <intervention_name>health education</intervention_name>
      <description>The number of sessions, duration, frequency, group size and delivery modality will be similar to the intervention group. The topics of the health education are the care of common diseases in the older adults, including hypertension, diabetes, osteoporosis, COPD, dementia, depression. Each session is about 70 min (same as intervention group), including 10-20 min lecture and 50-60 discussion and sharing.</description>
      <arm_group_label>Health education</arm_group_label>
    </intervention>
    <eligibility>
      <criteria>
        <textblock>
          Inclusion Criteria:&#xD;
  &#xD;
            1. Community-dwelling people aged 60 years or older&#xD;
  &#xD;
            2. Diagnosed with sarcopenia by the criteria of the Asian Working Group for Sarcopenia&#xD;
               (AWGS):&#xD;
  &#xD;
                 1. decreased muscle strength: handgrip strength of males &lt; 28 kg; handgrip strength&#xD;
                    of females &lt; 18 kg;&#xD;
  &#xD;
                 2. or decreased physical performance: the time of 5-time chair stand test ≥12 s;&#xD;
  &#xD;
                 3. or decreased muscle mass: SMI of males is &lt; 7.0 kg/m2; SMI of females is &lt; 5.7&#xD;
                    kg/m2&#xD;
  &#xD;
            3. Able to communicate and written and understand the instruction&#xD;
  &#xD;
          Exclusion Criteria:&#xD;
  &#xD;
            1. Been hospitalized for more than 5 days in the preceding 3 months&#xD;
  &#xD;
            2. Unable to have body composition test, such as having heart pacemaker, vascular stent,&#xD;
               steel plates and nails in the body&#xD;
  &#xD;
            3. Contraindications to exercise, such as severe musculoskeletal disorders, severe&#xD;
               cardiovascular diseases or spinal nerve injury&#xD;
  &#xD;
            4. Having regular exercise: 150-minute moderate-intensity activity or 75-minute&#xD;
               vigorous-intensity activity per week, with each session lasting at least 10 min in the&#xD;
               past 3 months based on self-reported time and a self-perceived intensity via Borg&#xD;
               Scale&#xD;
  &#xD;
            5. Practicing mindfulness/yoga for &gt;45 min a week in the 6 months prior to recruitment&#xD;
        </textblock>
      </criteria>
      <gender>All</gender>
      <minimum_age>60 Years</minimum_age>
      <maximum_age>N/A</maximum_age>
      <healthy_volunteers>No</healthy_volunteers>
    </eligibility>
    <overall_contact>
      <last_name>Patrick KOR, PhD</last_name>
      <phone>(852) 27665622</phone>
      <email>patrick.kor@polyu.edu.hk</email>
    </overall_contact>
    <location>
      <facility>
        <name>The Hong Kong Polytechnic University</name>
        <address>
          <city>Suzhou</city>
          <state>Jiangsu</state>
          <zip>215000</zip>
          <country>China</country>
        </address>
      </facility>
      <status>Recruiting</status>
      <contact>
        <last_name>Mengli LI, PhD</last_name>
        <phone>(86) 18351075005</phone>
        <email>mengli.li@connect.polyu.hk</email>
      </contact>
    </location>
    <location_countries>
      <country>China</country>
    </location_countries>
    <reference>
      <citation>Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019 Jun 29;393(10191):2636-2646. doi: 10.1016/S0140-6736(19)31138-9. Epub 2019 Jun 3. Erratum In: Lancet. 2019 Jun 29;393(10191):2590.</citation>
      <PMID>31171417</PMID>
    </reference>
    <reference>
      <citation>Mayhew AJ, Amog K, Phillips S, Parise G, McNicholas PD, de Souza RJ, Thabane L, Raina P. The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing. 2019 Jan 1;48(1):48-56. doi: 10.1093/ageing/afy106.</citation>
      <PMID>30052707</PMID>
    </reference>
    <reference>
      <citation>Cao L, Morley JE. Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code. J Am Med Dir Assoc. 2016 Aug 1;17(8):675-7. doi: 10.1016/j.jamda.2016.06.001. No abstract available.</citation>
      <PMID>27470918</PMID>
    </reference>
    <reference>
      <citation>Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyere O. Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. PLoS One. 2017 Jan 17;12(1):e0169548. doi: 10.1371/journal.pone.0169548. eCollection 2017.</citation>
      <PMID>28095426</PMID>
    </reference>
    <reference>
      <citation>Peng TC, Chen WL, Wu LW, Chang YW, Kao TW. Sarcopenia and cognitive impairment: A systematic review and meta-analysis. Clin Nutr. 2020 Sep;39(9):2695-2701. doi: 10.1016/j.clnu.2019.12.014. Epub 2019 Dec 17.</citation>
      <PMID>31917049</PMID>
    </reference>
    <reference>
      <citation>Chang KV, Hsu TH, Wu WT, Huang KC, Han DS. Is sarcopenia associated with depression? A systematic review and meta-analysis of observational studies. Age Ageing. 2017 Sep 1;46(5):738-746. doi: 10.1093/ageing/afx094.</citation>
      <PMID>28633395</PMID>
    </reference>
    <reference>
      <citation>Cho HW, Chung W, Moon S, Ryu OH, Kim MK, Kang JG. Effect of Sarcopenia and Body Shape on Cardiovascular Disease According to Obesity Phenotypes. Diabetes Metab J. 2021 Mar;45(2):209-218. doi: 10.4093/dmj.2019.0223. Epub 2020 Jul 10.</citation>
      <PMID>32662256</PMID>
    </reference>
    <reference>
      <citation>Yang M, Liu Y, Zuo Y, Tang H. Sarcopenia for predicting falls and hospitalization in community-dwelling older adults: EWGSOP versus EWGSOP2. Sci Rep. 2019 Nov 27;9(1):17636. doi: 10.1038/s41598-019-53522-6.</citation>
      <PMID>31776354</PMID>
    </reference>
    <reference>
      <citation>Nakamura K, Yoshida D, Honda T, Hata J, Shibata M, Hirakawa Y, Furuta Y, Kishimoto H, Ohara T, Kitazono T, Nakashima Y, Ninomiya T. Prevalence and Mortality of Sarcopenia in a Community-dwelling Older Japanese Population: The Hisayama Study. J Epidemiol. 2021 May 5;31(5):320-327. doi: 10.2188/jea.JE20190289. Epub 2020 Oct 17.</citation>
      <PMID>32507775</PMID>
    </reference>
    <reference>
      <citation>Su Y, Hirayama K, Han TF, Izutsu M, Yuki M. Sarcopenia Prevalence and Risk Factors among Japanese Community Dwelling Older Adults Living in a Snow-Covered City According to EWGSOP2. J Clin Med. 2019 Feb 28;8(3):291. doi: 10.3390/jcm8030291.</citation>
      <PMID>30823497</PMID>
    </reference>
    <reference>
      <citation>Bruyere O, Beaudart C, Ethgen O, Reginster JY, Locquet M. The health economics burden of sarcopenia: a systematic review. Maturitas. 2019 Jan;119:61-69. doi: 10.1016/j.maturitas.2018.11.003. Epub 2018 Nov 12.</citation>
      <PMID>30502752</PMID>
    </reference>
    <reference>
      <citation>Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, Kojima T, Kuzuya M, Lee JSW, Lee SY, Lee WJ, Lee Y, Liang CK, Lim JY, Lim WS, Peng LN, Sugimoto K, Tanaka T, Won CW, Yamada M, Zhang T, Akishita M, Arai H. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2. doi: 10.1016/j.jamda.2019.12.012. Epub 2020 Feb 4.</citation>
      <PMID>32033882</PMID>
    </reference>
    <reference>
      <citation>Hurst C, Robinson SM, Witham MD, Dodds RM, Granic A, Buckland C, De Biase S, Finnegan S, Rochester L, Skelton DA, Sayer AA. Resistance exercise as a treatment for sarcopenia: prescription and delivery. Age Ageing. 2022 Feb 2;51(2):afac003. doi: 10.1093/ageing/afac003.</citation>
      <PMID>35150587</PMID>
    </reference>
    <reference>
      <citation>Wu PY, Huang KS, Chen KM, Chou CP, Tu YK. Exercise, Nutrition, and Combined Exercise and Nutrition in Older Adults with Sarcopenia: A Systematic Review and Network Meta-analysis. Maturitas. 2021 Mar;145:38-48. doi: 10.1016/j.maturitas.2020.12.009. Epub 2020 Dec 31.</citation>
      <PMID>33541561</PMID>
    </reference>
    <reference>
      <citation>Yoshimura Y, Wakabayashi H, Yamada M, Kim H, Harada A, Arai H. Interventions for Treating Sarcopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. J Am Med Dir Assoc. 2017 Jun 1;18(6):553.e1-553.e16. doi: 10.1016/j.jamda.2017.03.019.</citation>
      <PMID>28549707</PMID>
    </reference>
    <reference>
      <citation>Li ML, Kor PP, Sui YF, Liu JY. Health maintenance through home-based interventions for community-dwelling older people with sarcopenia during and after the COVID-19 pandemic: A systematic review and meta-analysis. Exp Gerontol. 2023 Apr;174:112128. doi: 10.1016/j.exger.2023.112128. Epub 2023 Feb 21.</citation>
      <PMID>36804363</PMID>
    </reference>
    <reference>
      <citation>Reangsing C, Rittiwong T, Schneider JK. Effects of mindfulness meditation interventions on depression in older adults: A meta-analysis. Aging Ment Health. 2021 Jul;25(7):1181-1190. doi: 10.1080/13607863.2020.1793901. Epub 2020 Jul 15.</citation>
      <PMID>32666805</PMID>
    </reference>
    <reference>
      <citation>Goldberg SB, Tucker RP, Greene PA, Davidson RJ, Wampold BE, Kearney DJ, Simpson TL. Mindfulness-based interventions for psychiatric disorders: A systematic review and meta-analysis. Clin Psychol Rev. 2018 Feb;59:52-60. doi: 10.1016/j.cpr.2017.10.011. Epub 2017 Nov 8.</citation>
      <PMID>29126747</PMID>
    </reference>
    <reference>
      <citation>Wang S, Yin H, Jia Y, Zhao L, Wang L, Chen L. Effects of Mind-Body Exercise on Cognitive Function in Older Adults With Cognitive Impairment: A Systematic Review and Meta-analysis. J Nerv Ment Dis. 2018 Dec;206(12):913-924. doi: 10.1097/NMD.0000000000000912.</citation>
      <PMID>30507734</PMID>
    </reference>
    <verification_date>July 2023</verification_date>
    <study_first_submitted>July 7, 2023</study_first_submitted>
    <study_first_submitted_qc>July 30, 2023</study_first_submitted_qc>
    <study_first_posted type="Actual">August 8, 2023</study_first_posted>
    <last_update_submitted>July 30, 2023</last_update_submitted>
    <last_update_submitted_qc>July 30, 2023</last_update_submitted_qc>
    <last_update_posted type="Actual">August 8, 2023</last_update_posted>
    <responsible_party>
      <responsible_party_type>Principal Investigator</responsible_party_type>
      <investigator_affiliation>The Hong Kong Polytechnic University</investigator_affiliation>
      <investigator_full_name>Patrick KOR Pui Kin</investigator_full_name>
      <investigator_title>Assistant Professor</investigator_title>
    </responsible_party>
    <condition_browse>
      <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
      <mesh_term>Sarcopenia</mesh_term>
    </condition_browse>
    <!-- Results have not yet been posted for this study                                          -->
  </clinical_study>
  
  
text: download date: ClinicalTrials.gov processed this data on September 20, 2023
  link text: Link to the current ClinicalTrials.gov record.
  url: https://clinicaltrials.gov/ct2/show/NCT05982067
  org study id: Mindful PE Sarcope
  nct id: NCT05982067
  lead sponsor: 
  is fda regulated drug: No
  is fda regulated device: No
  The goal of this pilot randomized controlled trial (RCT) is to assess the feasibility,
        acceptability, and the preliminary effects of the MIndfulness-based Physical Exercise (MIPE)
        intervention among community-dwelling older people with sarcopenia. The main questions are:
        1) is the MIPE intervention feasible and acceptable in older adults with sarcopenia? 2) is
        the MIPE intervention effective to improve the adherence to physical exercise intervention,
        alleviate the symptoms of sarcopenia and enhance the psychological well-being of older adults
        with sarcopenia? To answer these questions, a MIPE intervention protocol was developed by
        Delphi approach and end-users' evaluation. This pilot RCT will be conducted to assess the
        feasibility, acceptability, and the preliminary effects of the MIPE intervention. In the
        parallel-group, pilot RCT, 60 community-dwelling older people aged 60 years or older
        diagnosed with sarcopenia will be randomized into either the intervention group receiving the
        MIPE intervention 2 sessions weekly over 12 weeks or the control group receiving health
        educations. Each session of the MIPE intervention will last about 70 minutes, including
        20-min mindfulness-based intervention, 40-min physical exercise (10-min warm-up, 20-min RE,
        and 10-min cool down) and 10-20-min sharing and discussion. The feasibility, acceptability
        and preliminary effectiveness on sarcopenia symptoms and psychological well-being of the MIPE
        program will be assessed.
  Background Sarcopenia is a geriatric syndrome characterised by low muscle mass, muscle
        strength, and physical function. Physical exercise (PE), especially resistance exercise, has
        demonstrated potential effects on sarcopenia. However, low motivation for regular PE is
        always reported as a major barrier in this population. Based on the PRIME (Plans, Responses,
        Impulses, Motives, and Evaluations) theory of motivation, Plan (i.e., well-planned, and
        evidence-based PE protocol), Motives (anticipated pleasure, satisfaction, and relief) and
        self-awareness on the present moment are the key points of human motivation and the potential
        targets to change a behaviour (i.e., adhering to a PE intervention) in older people with
        sarcopenia. Limited study on sarcopenia consisted of any interventional element to emphasise
        motives and self-awareness on the present moment, two key points of human motivation in the
        PRIME theory of motivation, although older people with sarcopenia are more likely to have
        negative feelings (i.e., fatigue, depress, anxiety) and experiences (i.e., derailed by daily
        life and distracted by concerns on PE). Mindfulness-based intervention (MBI) is a
        psychosocial intervention which aims to increase the participants' awareness of the present
        moment non-judgmentally. Increased evidence has indicated that MBI can also improve the
        levels of PE and adherence to PE interventions. Based on the mindful coping model, the
        positive relationship between mindfulness and PE might be that MBI has the potential to
        improve motivation for PE by addressing three key points of human motivation in the PRIME
        theory of motivation (focusing on the present moment, evoking positive feelings, and
        increasing self-awareness). Thus, MBI has the potential to be integrated into PE training to
        increase motivation and adherence to PE in older people with sarcopenia.
  
        To address the above research gaps, we first conducted a SR on the home-based interventions
        among community-dwelling older people with sarcopenia was conducted, showing that home-based
        resistance exercise is feasible, suitable and has potential effects on sarcopenia, but few
        studies consisted of motivation-enhancing component. Then a Delphi study was conducted to
        develop the MIndfulness-based Physical Exercise (MIPE) intervention on this population.
        However, the feasibility, acceptability, and effects of the HOME intervention among
        community-dwelling older people with sarcopenia need to be explored.
  
        Objective The objective of this study is to assess the feasibility, acceptability, and the
        preliminary effects of the MIPE intervention among community-dwelling older people with
        sarcopenia.
  
        Methods A pilot randomised controlled trial (RCT) will be conducted to assess the
        feasibility, acceptability, and the preliminary effects of the HOME intervention. In the
        parallel-group, pilot RCT, 60 community-dwelling older people aged 60 years or older
        diagnosed with sarcopenia will be randomised into either the intervention group receiving the
        HOME intervention 2 sessions weekly over 12 weeks or the control group receiving health
        educations. Each session of the HOME intervention will last about 70 minutes, including
        20-min MBI, 40-min HBE (10-min warm-up, 20-min RE, and 10-min cool down) and 10-20-min
        sharing and discussion. The feasibility of this programme will be determined by time spent
        recruiting participants, eligibility rate and recruitment rate. The acceptability of the HOME
        program will be assessed by: 1) prospective acceptability: recruitment rate and reasons for
        not involving in this study; 2) concurrent acceptability: attendance rate, complete rate,
        attrition rate and reasons for discontinuing; and 3) retrospective acceptability: the
        participants' perspectives on the intervention after taking part. Based on our conceptual
        framework, primary outcomes (muscle mass, muscle strength and physical function) and
        secondary outcomes (motivation, depressive symptoms, psychological well-being, mindfulness
        level and quality of life) will be assessed at baseline (T0), immediately post-intervention
        week 12 (T1) and 12 weeks after completion of the intervention. The quantitative data will be
        analysed by generalised estimating equations. The qualitative data will be Brun and Clark's
        thematic approach.
  
        Impact and significance The MIPE program, consisting MBI and PE, is novel in the research
        field related to sarcopenia, which addresses the limitations of previous studies. This study
        has the potential to improve the symptoms of sarcopenia, the motivation and adherence to PE
        as well as the psychological health of this population, which finally improves the holistic
        welling of this population and facilitates their "ageing in place". For researchers, this
        study provides a relatively new sub-area in this field by generating insights on the
        importance of the above factors and the potential effectiveness of the mindfulness-based PE.
        For health professionals, the study provides a potentially effective way to improve the
        motivation and adherence to PE to treat sarcopenia.
  allocation: Randomized
  intervention model: Parallel Assignment
  primary purpose: Treatment
  masking: Double (Investigator, Outcomes Assessor)
  masking description: Due to the character of the intervention and control group in this study (the mindfulness-based PE vs health education), it is impossible to blind participants. The interventionist (the qualified mindfulness instructor and sport coach) is also unrealizable to be blinded. To reduce the allocation bias as much as possible, the following personnel will be blinded: the research assistants who are responsible for the participants recruitment, the research assistants who perform the randomization and the assessor who collect data.
  measure: Time spent recruiting participants
  time frame: baseline (T0)
  description: The time spent recruiting participants is the period from the first day of recruiting participants to the last day of recruiting participants. This outcome will help us understand the feasibility of the MIPE program. Specifically, shorter time spent recruiting participants roughly reflects the higher feasibility of the MIPE program.
  measure: Eligibility rate
  time frame: baseline (T0)
  description: The eligibility rate will be calculated by the number of eligible participants/the number of screened participants. The higher eligibility indicates the more potential participants.
  measure: Recruitment rate
  time frame: baseline (T0)
  description: The recruitment rate will be calculated by the number of participants recruited/ the number of eligible participants. The higher recruitment rate indicates the higher willingness of the eligible participants to join the MIPE program.
  measure: Attendance rate
  time frame: week 12 (T1)
  description: The attendance rate will be calculated by the attended sessions of the participants/ all sessions. The higher attendance rate roughly indicates the higher involvement of the participants in the MIPE program.
  measure: Complete rate
  time frame: week 12 (T1)
  description: The complete rate will be calculated by the sessions that finished at least 80% / all attended sessions. The higher complete rate indicates the actual involvement of the participants in the MIPE program.
  measure: Attrition rate
  time frame: week 12 (T1)
  description: The attrition rate will be calculated by the number of participants dropped out total number of participants. If the participants engage in less than 80% of online sessions will be considered as attrition. The higher attrition rate indicates the lower participation in the MIPE program.
  measure: The participants' perspectives on the intervention
  time frame: week 12 (T1)
  description: The participants' perspectives on the intervention will be explored by individual interviews. There are mainly five questions in the individual interviews: 1) Generally, what do you think of this intervention? 2) What do you think of the content of this intervention? 3) What do you think of the frequency, duration and delivery mode of this intervention? 4) How about your motivation to exercise? 5) What recommendations do you have for this intervention? The results will help us to further revise and improve the MIPE to be more tailored to the older adults with sarcopenia. The individual interviews will be conducted by the PhD student who has received rigor trained in qualitative study methods and engaged in individual interviews before and a professor who has rich experience in conducting individual interviews and is familiar with sarcopenia and mindfulness.
  measure: Skeletal muscle mass index
  time frame: baseline (T0) and week 12 (T1, immediately post-intervention)
  description: Skeletal muscle mass index (SMI) will be assessed by Bioelectrical impedance analysis (Inbody 270, Korea). The procedure of testing is below: before the test, the participants will be required to remove every item that might influence the test, such as metal keys, bank cards, mobile phones, from their body, and then take off their shoes and socks. Then, they will be instructed to stand straight on the detector with two hands holding the handles of the detector for about one minute. During the testing, they will be not allowed to talk, move, or laugh. Higher Skeletal muscle mass index (SMI) means the higher muscle mass. Comparisons of changes of skeletal muscle mass index (SMI) will be considered as follows: baseline (T0)- week 12 (T1).
  measure: The Chinese version of the Behavioral Regulation in Exercise Questionnaire-2 (C-BREQ-2)
  time frame: baseline (T0) and week 12 (T1, immediately post-intervention)
  description: The Chinese version of the Behavioral Regulation in Exercise Questionnaire-2 (C-BREQ-2) assesses the motivation of the participants to exercise. The C-BREQ-2 is a self-report measure with 18-items and each item is rated on a 5-point Likert scale from 0 to 4, with a higher score indicating higher motivation to exercise. Comparison of change of the C-BREQ-2 will be considered as follows: baseline (T0)- week 12 (T1).
  measure: The Chinese version of the short form Geriatric Depression Scale (GDS-15)
  time frame: baseline (T0) and week 12 (T1, immediately post-intervention)
  description: The Chinese version of the short form Geriatric Depression Scale (GDS-15) assesses the depressive symptoms of the participants. The score of GDS ranges 0-15 with each "no" answers of item 1,5,7 and 11 scoring 1 while the rest items scoring 1 with "yes" answers. The classification of depressive symptoms based on the score is: score 0-4: normal; score 5-8: mild depression; score 9-11: moderate depression; score 12-15: severe depression. Comparison of change of the Chinese version of the GDS-15 will be considered as follows: baseline (T0)- week 12 (T1).
  measure: The Chinese version of Raff's Psychological Well-being Scale (RPWS-C)
  time frame: baseline (T0) and week 12 (T1, immediately post-intervention)
  description: The Chinese version of Raff's Psychological Well-being Scale (RPWS-C) assesses the psychological well-being of the participants. The RPWS-C has 24 items, and each item is rated from 1 (strongly disagree) to 6 (strongly agree), with higher score indicating higher psychological well-being. Comparison of change of the RPWS-C will be considered as follows: baseline (T0)- week 12 (T1).
  measure: The Chinese Version of the Physical Activity Scale for the Elderly (PASE-C)
  time frame: baseline (T0) and week 12 (T1, immediately post-intervention)
  description: The Chinese Version of the Physical Activity Scale for the Elderly (PASE-C) assesses the physical activity level of the participants. The PASE-C, consisting of 10-items, is a self-reported scale to measure the occupational, household, and leisure activities for the last seven days. Higher score of the PASE-C indicates higher physical activity. Comparison of change of the PASE-C will be considered as follows: baseline (T0)- week 12 (T1).
  measure: The Chinese version of Five Facet Mindfulness Questionnaire (FFMQ-15-C)
  time frame: baseline (T0) and week 12 (T1, immediately post-intervention)
  description: The Chinese version of Five Facet Mindfulness Questionnaire (FFMQ-15-C) assesses the mindfulness level of the participants. The FFMQ-15-C has 15 items and each item is rated on a 5-point Likert scale, ranging from1 = "never or very rarely true" to 5 = "very often or always true", with higher total scores indicating a higher degree of mindfulness. Comparison of change of the FFMQ-15-C will be considered as follows: baseline (T0)- week 12 (T1).
  measure: The Chinese version of Sarcopenia and Quality of life (SarQoL®)
  time frame: baseline (T0) and week 12 (T1, immediately post-intervention)
  description: The Chinese version of Sarcopenia and Quality of life (SarQoL®) assesses the quality of life of the participants. The SarQoL® has 22 items with higher score indicating higher quality of life. Comparison of change of the SarQoL® will be considered as follows: baseline (T0)- week 12 (T1).
  measure: Handgrip strength
  time frame: baseline (T0) and week 12 (T1, immediately post-intervention)
  description: Handgrip strength will be measured by Jamar dynamometer (Jamar, 563213, USA) and the method refers to the recommendation of American Society of Hand Therapists. Comparisons of changes of handgrip strength will be considered as follows: baseline (T0)- week 12 (T1).
  measure: 5-times Chair stand test
  time frame: baseline (T0) and week 12 (T1, immediately post-intervention)
  description: 5-times Chair stand test reflects the physical function and is an indicator in the sarcopenia diagnosis. The participants will be invited to stand and sit from a chair (about 43 cm) five times and the time will be recorded. Short time of the test, better physical function. Comparisons of changes of 5-times Chair stand test will be considered as follows: baseline (T0)- week 12 (T1).
  arm group label: mindfulness-based physical exercie
  arm group type: Experimental
  description: The participants will receive about 70-min MIPE program twice a week, which will be conducted in a hybrid way, a combination of face-to-face and at home by a qualified mindfulness therapist and a sport coach.
  arm group label: Health education
  arm group type: Placebo Comparator
  description: Health education consisting of discussion provided by a registered nurse will be conducted as a control of socialization and interaction.
  intervention type: Other
  intervention name: mindfulness-based phsycial exercise intervention
  description: The intervention is 12 weeks, two times a week. The MIPE intervention will be conducted in a hybrid way, a combination of face-to-face and at home, by a qualified mindfulness therapist and a qualified sport coach. Specifically, the participants will attend the face-to-face sessions once every two weeks and in other weeks, they will perform the intervention at home using videos and templates. The face-to-face sessions will be conducted at the health care centre. The intervention of each session will include 1) introduce the theme of this session, 2) mini lectures about the theme; 3) mindfulness practice related to the theme; 4) tips of keeping mindfulness during PE; 5) warm up: lead with mindfulness words; 6) resistance exercise; 7) cool down: lead with mindfulness words; 8) discussion.
  arm group label: mindfulness-based physical exercie
  intervention type: Other
  intervention name: health education
  description: The number of sessions, duration, frequency, group size and delivery modality will be similar to the intervention group. The topics of the health education are the care of common diseases in the older adults, including hypertension, diabetes, osteoporosis, COPD, dementia, depression. Each session is about 70 min (same as intervention group), including 10-20 min lecture and 50-60 discussion and sharing.
  arm group label: Health education
  criteria: 
  gender: All
  minimum age: 60 Years
  maximum age: N/A
  healthy volunteers: No
  last name: Patrick KOR, PhD
  phone: (852) 27665622
  email: patrick.kor@polyu.edu.hk
  facility: 
  status: Recruiting
  contact: 
  country: China
  citation: Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019 Jun 29;393(10191):2636-2646. doi: 10.1016/S0140-6736(19)31138-9. Epub 2019 Jun 3. Erratum In: Lancet. 2019 Jun 29;393(10191):2590.
  PMID: 31171417
  citation: Mayhew AJ, Amog K, Phillips S, Parise G, McNicholas PD, de Souza RJ, Thabane L, Raina P. The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing. 2019 Jan 1;48(1):48-56. doi: 10.1093/ageing/afy106.
  PMID: 30052707
  citation: Cao L, Morley JE. Sarcopenia Is Recognized as an Independent Condition by an International Classification of Disease, Tenth Revision, Clinical Modification (ICD-10-CM) Code. J Am Med Dir Assoc. 2016 Aug 1;17(8):675-7. doi: 10.1016/j.jamda.2016.06.001. No abstract available.
  PMID: 27470918
  citation: Beaudart C, Zaaria M, Pasleau F, Reginster JY, Bruyere O. Health Outcomes of Sarcopenia: A Systematic Review and Meta-Analysis. PLoS One. 2017 Jan 17;12(1):e0169548. doi: 10.1371/journal.pone.0169548. eCollection 2017.
  PMID: 28095426
  citation: Peng TC, Chen WL, Wu LW, Chang YW, Kao TW. Sarcopenia and cognitive impairment: A systematic review and meta-analysis. Clin Nutr. 2020 Sep;39(9):2695-2701. doi: 10.1016/j.clnu.2019.12.014. Epub 2019 Dec 17.
  PMID: 31917049
  citation: Chang KV, Hsu TH, Wu WT, Huang KC, Han DS. Is sarcopenia associated with depression? A systematic review and meta-analysis of observational studies. Age Ageing. 2017 Sep 1;46(5):738-746. doi: 10.1093/ageing/afx094.
  PMID: 28633395
  citation: Cho HW, Chung W, Moon S, Ryu OH, Kim MK, Kang JG. Effect of Sarcopenia and Body Shape on Cardiovascular Disease According to Obesity Phenotypes. Diabetes Metab J. 2021 Mar;45(2):209-218. doi: 10.4093/dmj.2019.0223. Epub 2020 Jul 10.
  PMID: 32662256
  citation: Yang M, Liu Y, Zuo Y, Tang H. Sarcopenia for predicting falls and hospitalization in community-dwelling older adults: EWGSOP versus EWGSOP2. Sci Rep. 2019 Nov 27;9(1):17636. doi: 10.1038/s41598-019-53522-6.
  PMID: 31776354
  citation: Nakamura K, Yoshida D, Honda T, Hata J, Shibata M, Hirakawa Y, Furuta Y, Kishimoto H, Ohara T, Kitazono T, Nakashima Y, Ninomiya T. Prevalence and Mortality of Sarcopenia in a Community-dwelling Older Japanese Population: The Hisayama Study. J Epidemiol. 2021 May 5;31(5):320-327. doi: 10.2188/jea.JE20190289. Epub 2020 Oct 17.
  PMID: 32507775
  citation: Su Y, Hirayama K, Han TF, Izutsu M, Yuki M. Sarcopenia Prevalence and Risk Factors among Japanese Community Dwelling Older Adults Living in a Snow-Covered City According to EWGSOP2. J Clin Med. 2019 Feb 28;8(3):291. doi: 10.3390/jcm8030291.
  PMID: 30823497
  citation: Bruyere O, Beaudart C, Ethgen O, Reginster JY, Locquet M. The health economics burden of sarcopenia: a systematic review. Maturitas. 2019 Jan;119:61-69. doi: 10.1016/j.maturitas.2018.11.003. Epub 2018 Nov 12.
  PMID: 30502752
  citation: Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, Jang HC, Kang L, Kim M, Kim S, Kojima T, Kuzuya M, Lee JSW, Lee SY, Lee WJ, Lee Y, Liang CK, Lim JY, Lim WS, Peng LN, Sugimoto K, Tanaka T, Won CW, Yamada M, Zhang T, Akishita M, Arai H. Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment. J Am Med Dir Assoc. 2020 Mar;21(3):300-307.e2. doi: 10.1016/j.jamda.2019.12.012. Epub 2020 Feb 4.
  PMID: 32033882
  citation: Hurst C, Robinson SM, Witham MD, Dodds RM, Granic A, Buckland C, De Biase S, Finnegan S, Rochester L, Skelton DA, Sayer AA. Resistance exercise as a treatment for sarcopenia: prescription and delivery. Age Ageing. 2022 Feb 2;51(2):afac003. doi: 10.1093/ageing/afac003.
  PMID: 35150587
  citation: Wu PY, Huang KS, Chen KM, Chou CP, Tu YK. Exercise, Nutrition, and Combined Exercise and Nutrition in Older Adults with Sarcopenia: A Systematic Review and Network Meta-analysis. Maturitas. 2021 Mar;145:38-48. doi: 10.1016/j.maturitas.2020.12.009. Epub 2020 Dec 31.
  PMID: 33541561
  citation: Yoshimura Y, Wakabayashi H, Yamada M, Kim H, Harada A, Arai H. Interventions for Treating Sarcopenia: A Systematic Review and Meta-Analysis of Randomized Controlled Studies. J Am Med Dir Assoc. 2017 Jun 1;18(6):553.e1-553.e16. doi: 10.1016/j.jamda.2017.03.019.
  PMID: 28549707
  citation: Li ML, Kor PP, Sui YF, Liu JY. Health maintenance through home-based interventions for community-dwelling older people with sarcopenia during and after the COVID-19 pandemic: A systematic review and meta-analysis. Exp Gerontol. 2023 Apr;174:112128. doi: 10.1016/j.exger.2023.112128. Epub 2023 Feb 21.
  PMID: 36804363
  citation: Reangsing C, Rittiwong T, Schneider JK. Effects of mindfulness meditation interventions on depression in older adults: A meta-analysis. Aging Ment Health. 2021 Jul;25(7):1181-1190. doi: 10.1080/13607863.2020.1793901. Epub 2020 Jul 15.
  PMID: 32666805
  citation: Goldberg SB, Tucker RP, Greene PA, Davidson RJ, Wampold BE, Kearney DJ, Simpson TL. Mindfulness-based interventions for psychiatric disorders: A systematic review and meta-analysis. Clin Psychol Rev. 2018 Feb;59:52-60. doi: 10.1016/j.cpr.2017.10.011. Epub 2017 Nov 8.
  PMID: 29126747
  citation: Wang S, Yin H, Jia Y, Zhao L, Wang L, Chen L. Effects of Mind-Body Exercise on Cognitive Function in Older Adults With Cognitive Impairment: A Systematic Review and Meta-analysis. J Nerv Ment Dis. 2018 Dec;206(12):913-924. doi: 10.1097/NMD.0000000000000912.
  PMID: 30507734
  responsible party type: Principal Investigator
  investigator affiliation: The Hong Kong Polytechnic University
  investigator full name: Patrick KOR Pui Kin
  investigator title: Assistant Professor
  mesh term: Sarcopenia